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The two-protein complex between putidaredoxin
(Pdx) and cytochrome P450cam (CYP101) is the cata-
lytically competent species for camphor hydroxyl-
ation by CYP101. We detected a conformational
change in CYP101 upon binding of Pdx that reorients
bound camphor appropriately for hydroxylation.
Experimental evidence shows that binding of Pdx
converts a single X-proline amide bond in CYP101
from trans or distorted trans to cis. Mutation of pro-
line 89 to isoleucine yields a mixture of both bound
camphor orientations, that seen in Pdx-free and
that seen in Pdx-bound CYP101. A mutation in
CYP101 that destabilizes the cis conformer of the
Ile 88-Pro 89 amide bond results in weaker binding
of Pdx. This work provides direct experimental evi-
dence for involvement of X-proline isomerization in
enzyme function.
INTRODUCTION
Enzyme catalysis requires enzymemotion, a concept that is now
generally appreciated. The structural requirements for selective
binding of substrates, stabilization of transition states, and prod-
uct release by an enzyme appear to be mutually exclusive. How-
ever, they can be reconciled by assuming that each step in the
catalytic cycle takes place from an appropriate enzyme confor-
mation, with sequentially occupied conformations linked to one
another by motions with frequencies low enough so that the
individual states are discrete on the timescale of catalysis. Alter-
natively, conformational changes can be driven by binding of
a cofactor or an effector. A complete catalytic cycle would start
in the resting state (which may or may not be the enzyme confor-
mation receptive to substrate binding) and pass through confor-
mations that sequentially stabilize substrate binding, reaction
transition state(s), and finally product release.
We are using nuclear magnetic resonance (NMR) methods
to investigate such conformational changes in cytochrome
P450cam (CYP101) from Pseudomonas putida. CYP101 catal-
yzes the hydroxylation of camphor at the unactivated 5-exo
C-H bond by molecular oxygen, the first step in camphor catab-
olism by P. putida. Such selective oxidations are among the
most mechanistically complex chemical reactions that occur in
living organisms. Nevertheless, CYP101 carries out the stereo-916 Structure 16, 916–923, June 2008 ª2008 Elsevier Ltd All rightsand regioselective oxidation of camphor with better than 99%
efficiency at room temperature, and at a rate sufficient to supply
all of the carbon and energy requirements of Pseudomonas
growth and reproduction in the absence of other reduced carbon
sources. Much of our current understanding of structure and
function in the P450 superfamily comes from in-depth investiga-
tions of CYP101 that span over 40 years, and have involved hun-
dreds of researchers (Mueller et al., 1995; Poulos, 2003; Katagiri,
2005). Despite this, there remain some crucial unresolved mech-
anistic questions regarding CYP101 that have relevance for
other P450 enzymes aswell. One outstanding question concerns
the role of conformational changes induced by effector binding
in the stimulation of catalytic activity in CYP101. It has long
been known that the physiological reductant of CYP101, the
Cys4Fe2S2 ferredoxin putidaredoxin (Pdx), is an effector and is
a required component of the catalytically competent CYP101
enzyme system (Lipscomb et al., 1976). In the absence of Pdx,
no product formation is observed under standard assay condi-
tions, even if a reductant of appropriate potential is present to
provide the required electrons. As other P450s have become
better characterized, it appears that the requirement for an effec-
tor is the norm rather than the exception (Urushino et al., 2006;
Zhang et al., 2005, 2006). The origin of effector activity in all
cases remains unclear. Electronic changes that occur in the
heme of CYP101 upon Pdx binding have been proposed to be
important in facilitating the second electron transfer (Unno
et al., 2002; Sjodin et al., 2001). However, effector activity has
been observed with molecules that do not induce such elec-
tronic changes, suggesting that the origin of such activity lies
elsewhere.
With 80% of the backbone 1H-, 15N-, and 13C-NMR reso-
nances in the reduced (Fe+2) CO- and camphor (S)-bound form
of the 414 residue monomeric CYP101 (CYP-S-CO) now
assigned (Pochapsky et al., 2003; Rui et al., 2006; OuYang
et al., 2006), we can obtain detailed and localized information
on conformational changes in this enzyme. CYP-S-CO is iso-
electronic with the physiologically relevant reduced camphor-
bound O2 complex of CYP101 (CYP-S-O2) upon which effectors
act, but is more convenient than CYP-S-O2 for equilibrium NMR
studies because it does not lead to product formation. Titration
of CYP-S-CO with reduced Pdx (Pdxr) causes conformational
perturbations in CYP101 remote from the Pdx binding site
(Pochapsky et al., 2003).Many of these perturbations are located
in regions of CYP101 that have been implicated in substrate
access to and orientation within the active site (Raag and Poulos,
1989). Based on these observations, we proposed a model for
effector activity in which the binding of Pdx forces selection ofreserved
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strate and/or intermediate during the reaction cycle (Pochapsky
et al., 2003). Support for this model was provided by the detec-
tion of a conformational shift that takes place in the active site of
CYP101 upon Pdx binding and results in a reorientation of bound
substrate in the active site (Wei et al., 2005). We found that 1H
chemical shifts of the methyl groups of bound camphor at satu-
rating Pdx concentrations matched those calculated from the
crystallographic structure of CYP-S-CObetter than the shifts ob-
served in the absence of Pdx, indicating that the crystallographic
conformation of CYP-S-CO most resembles the Pdx-bound
form in solution. A molecular dynamics simulation restrained
by the 1H chemical shifts of camphor observed in Pdx-free
CYP-S-CO suggested that the active site cavity of CYP101, in
the absence of Pdxr, expands relative to the crystallographically
determined cavity in order to accommodate the alternate cam-
phor orientation (Wei et al., 2005). Repositioning of bound sub-
strate in response to changing conditions has been observed
in other P450 enzymes as well (Jovanovic et al., 2005; Ravindra-
nathan et al., 2007).
The timescale of the conformational change induced in CYP-
S-CO by Pdxr is intriguing. Line widths of NH correlations in
TROSY-HSQC spectra of CYP-S-CO that shift upon titration
with Pdxr as well as the timescales of observed chemical shift
changes indicate that the conformational change takes place
with a kex between 150 and 200 s
1 at half-saturation at 25C
(Figure 1; Pochapsky et al., 2003; Wei et al., 2005). Recently,
Glascock et al. (2005) described a corresponding conforma-
tional change with a rate constant of 150 s1 at 25C upon titra-
tion of the active intermediate complex, CYP-S-O2, with Pdx
r by
using time-resolved optical spectroscopy. The timescale of the
conformational change suggested to us that a cis-trans isomer-
ization of an X-proline (X-Pro) amide might be involved. While
uncatalyzed X-Pro cis-trans isomerizations are considerably
slower than this (0.01 s1 in isolated peptides [Stein, 1993]),
enzymes that catalyze such isomerizations (peptide prolyl isom-
erases [PPIases]), e.g., cyclophylin A (CyA) and FK506-binding
protein (FKBP), can increase isomerization rates by up to six
orders of magnitude (Hur and Bruice, 2002). X-Pro peptide
bond isomerization has been implicated in a number of biological
switches involved in ion transport (Lummis et al., 2005;
Andreotti, 2006), gene expression (Nelson et al., 2006), and sig-
nal transduction (Sarkar et al., 2007), among others (Grochulski
et al., 1994; Andreotti, 2003).We therefore decided to investigate
the possibility that the conformational change induced by Pdxr
binding to CYP101 involves an X-Pro isomerization.
One residue in particular, Pro 89, seemed to be a likely candi-
date for isomerization. Pro 89 is one of three prolines identified in
all crystal structures of CYP101 as being in a cis conformation
(uCa88-C88-N89-Ca89 = 0
) around the peptide bond with the previ-
ous residue (Ile 88), and the only one of the three not involved in
a regular type VI turn (Poulos et al., 1987). The carbonyl oxygen
of Pro 89 provides the N-terminal hydrogen bond acceptor sta-
bilizing the B0 helix (residues 90–96), which is the secondary
structural element in CYP101 most uniformly perturbed by bind-
ing of Pdx. Tyr 96, the last residue in the B0 helix, provides a hy-
drogen bond to the carbonyl of bound camphor, and the B0 helix
has also been implicated in gating access to the CYP101 active
site (Poulos et al., 1986; Wade et al., 2004; Yao et al., 2007). AsStructuresuch, the conformation of the Ile 88-Pro 89 amide bond is impor-
tant in determining the shape and accessibility of the active site
of CYP101. We now report the results of spectroscopic and site-
directed mutagenesis experiments indicating that isomerization
of the Ile 88-Pro 89 amide is responsible for the high-barrier con-
formational change that takes place in CYP101 upon Pdxr bind-
ing and leads to the catalytically competent conformation of
CYP-S-O2 prior to the second electron transfer and subsequent
hydroxylation.
RESULTS
Population of a cis X-Pro Conformation in WT CYP-S-CO
Driven by Pdx Binding
A sample of WT CYP-S-CO selectively labeled with 1H,13C-pro-
line and isoleucine but otherwise uniformly labeled with 2H and
15Nwas titratedwith perdeuterated Pdxr. Due to spectral overlap
(there are 30 prolines in CYP101), we were unable to definitively
assign the proline ring 1H and 13C resonances of Pro 89, even in
the selectively labeled sample. However, a difference spectrum
obtained by subtracting the 1H,13C HSQC spectrum of Pdx-free
WT CYP-S-CO from that of the same sample saturated with four
equivalents of Pdxr shows a correlation that appears or is greatly
intensified in the Pdx-bound form in a spectral region considered
diagnostic for a cis-proline Cg (Figure 2; Dorman and Bovey,
1973; Schubert et al., 2002). This is evidence for population of
a cis X-Pro conformation in the Pdx-bound CYP-S-CO that is
absent or only lightly populated in the absence of Pdx. Further-
more, weak NOEs appearing in the region expected for proline
CdH protons to the NH of Arg 90 in the
15N-edited NOESY spec-
trum of Pdx-free CYP-S-CO are consistent with a largely trans
conformation of the 88-89 bond in the absence of Pdxr (see
the Supplemental Data available online).
Site-Directed Mutagenesis
Three proline residues in CYP101, Pro 86, Pro 89, and Pro 106,
were tested for their potential involvement in the conformational
change that accompanies Pdxr binding to CYP-S-CO. These
residues were chosen based on their locations in regions af-
fected by Pdx binding as determined by NMR titration and
inspection of likely structural consequences of isomerization.
Pro 86, in the B-B0 loop, stabilizes the positions of Phe 87 (which
is in van der Waals contact with substrate) and the B0 helix.
Mutations at Pro 86 result in marked loss of binding affinity for
Pdxr (KD = 450 mM for the P86V mutant CYP-S-CO versus
32 mM for WT at 298 K, as measured by NMR titration), but
also multiple conformations of camphor in the active site that
are not observed in WT, as determined by 1H-NMR. Mutations
at Pro 106, which provide the N-terminal cap for the C helix in
the Pdx-binding site (Figure 3), resulted in low expression levels
and poor enzyme stability. However, mutations at Pro 89, the
carbonyl of which provides the N-terminal hydrogen bond ac-
ceptor of the B0 helix (Figure 3), unambiguously give rise to the
same two camphor orientations in the active site that are
observed to interconvert in WT CYP-S-CO upon Pdxr binding.
The proline to isoleucine mutant P89I yields the two conforma-
tions in approximately equal amounts (Figure 4), and thus was
chosen for further investigation.16, 916–923, June 2008 ª2008 Elsevier Ltd All rights reserved 917
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OH group of Tyr 29 stabilizes the cis conformer of the Ile 88-Pro
89 amide by hydrogen bonding with the carbonyl oxygen of Ile 88
(Figure 3). Whereas the Y29F mutation introduces only minor
perturbations in the TROSY-HSQC spectrum of CYP-S-CO,
the mutation increases the KD for Pdx
r binding to Y29F CYP-S-
CO by an order of magnitude relative to WT (32 ± 10 mM for
WT versus 441 ± 202 mM for Y29F at 25C).
Both the P89I and Y29F mutants produce hydroxycamphor
in the standard reconstituted camphor hydroxylase assay, al-
though at rates slower than WT. Y29F catalyzed the oxidation
of NADH with a Vmax that was 75% that of WT, whereas P89I
exhibited a Vmax that was 25% of WT. No significant uncou-
pling of camphor hydroxylation from NADH consumption was
observedwith either the P89I or Y29Fmutants; ratios of hydroxy-
camphor product to reducing equivalents (NADH) consumed
were the same as for WT within experimental error. However,
the P89I mutant does not produce any detectable hydroxycam-
phor when sodium dithionite is used as a reductant in the ab-
sence of Pdx under single-turnover conditions at 4C, although
some product formation was observed with both WT and the
L358P mutant, in which camphor is found primarily in the orien-
tation induced by Pdx binding to WT (Tosha et al., 2004; OuYang
et al., 2006). We speculate that the lack of product from P89I in
Figure 2. Expansion of the 800 MHz 1H,13C
HSQC Spectrum of 1H,13C-Pro, Ile-u-2H,
15N-Labeled WT CYP-S-CO, Showing
Details of the Region Corresponding to
CgH2 Proline Correlations
The spectrum is shown in green. Overlaid in blue is
the difference spectrum obtained by subtracting
the spectrum obtained in the absence of Pdx
from one obtained upon saturation with 4 eq. of
Pdxr present. The difference spectrum in blue
shows increased peak intensity for Pdxr-saturated
CYP-S-CO in the region between 23 and 24 ppm
in the 13C dimension, where Cg chemical shifts
are observed for cis X-Pro.
Figure 1. The Timescale of the Pdxr-
Induced Conformational Change in WT
CYP-S-CO at 298 K Is Bracketed by Reso-
nancesShowingSlow versus Fast Exchange
Behavior in the Course of Titration by Pdxr
The left-hand figure shows the titration of the
amide HN correlation of Cys 357 (which provides
the heme iron axial thiolate ligand) as followed in
800 MHz 1H, 15N TROSY-HSQC spectra. A dis-
crete signal is observed at each titration point,
indicating fast-exchange behavior. The total 1H
chemical-shift change upon saturation with Pdxr
relative to the Pdx-free form (dsat  dfree) for Cys
357 HN is 0.17 ppm (136 Hz). The right-hand panel
shows the HN correlation for the adjacent residue,
Leu 358, from the same series of spectra. Discrete
signals are seen only at the extrema of the titration
(no Pdxr and saturating Pdxr), indicating slow-ex-
change behavior. The (dsat  dfree) for Leu 358 is
0.58 ppm (464 Hz). The rate for Pdx-induced con-
formational exchange at 298 K and half-saturation was estimated to be between 150 s1 and 300 s1 from line width and chemical-shift measurements (Pochap-
sky et al., 2003;Wei et al., 2005). Current data further restrict this range to between 150 s1 and 200 s1 (see the Supplemental Data). Spectrum colors correspond
to relative concentrations of CYP-S-CO and Pdxr: black, no Pdx; cyan, 5:1 CYP:Pdx; magenta, 2:1; blue, 1:1; green, 1:2; red, 1:4 (saturating Pdxr). All spectra
were obtained at 298 K.918 Structure 16, 916–923, June 2008 ª2008 Elsevier Ltd All rights reserved
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between conformers, making side reactions more competitive;
however, more detailed kinetic experiments are required to
confirm this.
Two other prolines, Pro 100 and Pro 105, are located in the
Pdx-perturbed regions of CYP101. Isomerization of Pro 105
seems unlikely in that it precedes Pro 106 (vide supra) and
should be too sterically restrained to readily undergo isomeriza-
tion. Furthermore, the destabilization and low expression levels
observed upon mutation of Pro 106 suggest that a well-defined
conformation in this region of the polypeptide is required for cor-
rect folding and/or heme incorporation. The proximity of Pro 100
to the heme and the number of critical tertiary contacts in this
region suggested to us that mutation of Pro 100 would also be
seriously destabilizing; thus, we instead chose to mutate His
355, which could be in a position to catalyze a cis-trans isomer-
ization of Pro 100 via a general acid mechanism. However, all
three His 355 mutants that we made, H355F, H355D, and
H355N, showed loss of heme upon exposure to air, suggesting
that heme is oxidatively degraded in the His 355 mutants.
Localization of Perturbations Due to the P89I Mutation
and Selective Pdx Binding to One Conformer of P89I
1H,15N correlations in TROSY-HSQC of P89I CYP-S-CO spectra
allow us to identify two conformations at slow exchange on the
Figure 3. Peptide Backbone Structure of Relevant Portions of the
CYP101 Structure Showing the Locations of Mutations Described
in the Text
Backbone positions of mutated residues are red. Others are color coded
according to secondary structural features. The position of Pro 86 (not shown)
is almost directly in front of the first turn of the B0 helix. The heme porphyrin is
shown with light lines, and the iron is shown as a small red polygon. Substrate
camphor (CAM) and carbon monoxide ligand are cyan. The hydrogen bond
between the carbonyl oxygen of Ile 88 and phenolic OH of Tyr 29 that stabilizes
the cis conformation of the Ile 88-Pro 89 amide is indicated by a dotted line.
The figure was generated by using MOLMOL (Koradi et al., 1996).Structure1H chemical shift timescale in an 50/50 mixture, as indicated
by doubling of NMR resonances in the mutant (Figures 4 and
5). In addition to the aforementioned doubling of the 1H methyl
resonances of bound camphor (Figure 4), doubling is confined
to residues spatially adjacent to the P89I mutation (b3 and b5
strands), residues in the active site that interact with bound cam-
phor, residues in the B-B0 loop and in B0 and I helices, and resi-
dues that are mechanically linked to the B-B0 loop and to B0 and I
helices (see the Supplemental Data). The 1:1 ratio of the two
forms indicates that the cis conformation of the Ile 88-Ile 89
bond is stabilized and/or the trans conformation is destabilized
by the local protein environment, since, in isolated nonprolyl
peptide bonds, the trans conformation is favored by 2.5 kcal/
mol, corresponding to only a 1.5% cis conformation at ambient
temperature (Pal and Chakrabarti, 1999). Molecular modeling
indicates that the hydrophobic side chain of Ile 89 is solvent
exposed in the trans conformation, but not in the cis conforma-
tion, which would destabilize the trans conformation. The cis
conformation is also stabilized by hydrogen bonding from Tyr
29 (vide supra), an interaction that molecular modeling indicates
is not available for the trans form. Both of these factors are likely
to contribute to the observed cis-trans ratio in P89I.
Figure 4. Upfield Regions of the 800 MHz 1H-NMR Spectra of
Perdeuterated WT and P89I CYP-S-CO Showing the 8-, 9-, and
10-CH3 Resonances of Camphor Bound in the CYP101 Active Site
WT is shown in red; P89I is shown in blue. The structure of camphor is shown at
the upper right. Arrows above the P89I spectrum with assignments labeled
with an asterisk indicate the positions of the 8- and 9-CH3 resonances ob-
served in Pdxr-saturated WT CYP-S-CO (Wei et al., 2005). These correspond
to the positions of one set of signals assigned to the 8- and 9-CH3 groups in
P89I. The two camphor orientations observed at slow exchange in P89I thus
correspond to the different camphor orientations seen in the Pdxr-free and
Pdxr-bound forms of WT CYP-S-CO. The position of the 10-CH3 resonance
in WT CYP-S-CO is not significantly perturbed by Pdxr binding (Wei et al.,
2005).16, 916–923, June 2008 ª2008 Elsevier Ltd All rights reserved 919
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A Proline Switch in Cytochrome P450camFigure 5. Corresponding Resonances in the
800 MHz 1H, 15N TROSY-HSQC Spectra of
WT and P89I CYP-S-CO Showing Splitting
of Resonances Due to Two Conformations
at Slow Exchange in the P89I Mutant
WT is shown in red; P89I is shown in black. Ile 88
immediately precedes Pro 89, and the side chain
of Ile 395, which is adjacent to Gly 394, is in van
der Waals contact with Ile 88 NH.For most NH correlations split by the P89I mutation, only one
of the pair of resonances is perturbed by the addition of Pdxr
(Figure 6). Because of spectral complexity, it was not possible
to accurately measure the KD of Pdx
r for the affected conformer.
However, it is striking that, in many cases, the first addition of
Pdxr to the sample resulted in the disappearance of one of
a pair of correlations associated with a single residue, whereas
the other member of the pair was unaffected or only weakly per-
turbed (see the Supplemental Data). This indicates that either
one of the two conformers interacts preferentially with Pdxr or
that Pdx drives a conformational change in only one of the two
conformers.
DISCUSSION
The hypothesis driving the current work is that binding of Pdxr to
CYP-S-CO drives isomerization of the Ile 88-Pro 89 amide bond
from a trans or distorted trans conformation in the absence of
Pdxr to one that is cis in the Pdxr-bound form. Furthermore, we
propose that the structural perturbations detected by NMR in
the active site and other distal locations of CYP-S-CO upon
Pdxr binding at the proximal face are due primarily to this isom-
erization. Mutation of Pro 89 to Ile results in population of both cis
and trans conformations around the Ile 88-Ile 89 amide bond in
P89I CYP-S-CO, as reflected by the doubling of NMR signals
from residues affected by the mutation. The two conformations
are at slow exchange on the chemical shift timescale in the
P89I mutant, which is expected since the barrier to cis-trans
isomerization is raised considerably in X-Y peptides when Y is
not proline (Schulz and Schirmer, 1979). Based on the ratios of
split signal intensities, the two conformers are roughly equal in
energy in the P89I mutant, although line width differences be-
tween the split signals for many residues suggest that the two
conformers have different dynamics on the millisecond time-
scale in some regions of the enzyme (see Figures 5 and 6 and
Supplemental Data). The 1H resonances of the 8- and 9-methyl
groups of bound camphor indicate that camphor occupies two
equally populated orientations in the active site of P89I (Figure 4),
and that these orientations are identical to the two camphor ori-
entations found to interconvert in WT CYP-S-CO as a function of
Pdxr binding (Wei et al., 2005). Furthermore, those residues
affected by the P89I mutation (as determined by doubling of
NMR resonances) are, for the most part, also those perturbed
by Pdxr binding in WT CYP-S-CO. In particular, the NH correla-
tions of residues Gly 248-Val 253 in the I helix, all of which are
strongly affected by the P89I mutation, show the largest pertur-920 Structure 16, 916–923, June 2008 ª2008 Elsevier Ltd All rights rbations of any distal residues in WT CYP-S-CO upon Pdxr bind-
ing (Rui et al., 2006). The NH correlations of Gly 248, Gly 249, Asp
251, Thr 252, and Val 253 in WT CYP-S-CO all respond to Pdxr
binding in the slow-exchange regime, that is, with 1H chemical
shift changes greater than 200 Hz (Figure 7). Poulos and co-
workers noted that the I helix is distorted in (cis-Ile 88-Pro 89
conformer) crystallographic structures between Gly 248 and
Thr 252, and that the Thr 252 OgH side chain hydroxyl acts as
the proton donor to the carbonyl of Gly 248, replacing the i, i+4
hydrogen bond from the Gly 248 carbonyl to the NH of Thr 252
expected in a-helical structures. This distortion opens a gap in
the I helix that provides a pocket to accommodate the Fe-bound
O2 in the appropriate orientation for chemistry (Poulos, 2007).
Clearly, both the binding of Pdx toWTCYP101 and perturbations
introduced by the mutation of Pro 89 result in changes in the O2
Figure 6. Pdxr Interacts Preferentially with One Conformer of P89I
CYP-S-CO, as Detected by TROSY-1H, 15N HSQC
Only one of the split resonances of Asn 59 (the nearest nonsequential contact
to Ile 89) titrates upon addition of Pdxr, whereas the other is unperturbed. The
scale on the P89I spectrum has been increased relative to WT for clarity. All
spectra were obtained at 800 MHz 1H and 298 K with sample conditions as
described in the Experimental Procedures.eserved
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the B0 helix are coupled to conformational changes in the I helix
by interactions between the side chains of Phe 98 and Ile 99 in
the B0-C loop with Met Leu 244 and Met 241 in the I helix
(Figure 3).
Evidence for Pdxr-Enforced Population of the cis
Conformation of the Ile 88-Pro 89 Bond in CYP-S-CO
There are several reasons to conclude that the crystallographi-
cally observed cis conformer of the Ile 88-Pro 89 bond is also
that favored upon binding of Pdxr. First, we see the appearance
of an upfield proline 13Cg signal in the Pdxr-bound WT CYP-S-
CO that is either absent or much less intense in the Pdxr-free
form (Figure 2). An upfield-shifted proline 13Cg is usually diag-
nostic of a cis X-Pro conformation. Second, we found that 1H
ring-current shifts calculated for themethyl resonances of bound
camphor from the (cis) 3CPP crystal structure are in better
agreement with the shifts observed for the Pdxr-bound CYP-S-
CO than are those seen for the Pdx-free form (Wei et al., 2005).
Results from the Y29Fmutant of CYP101 also support the idea
that the cis conformer is favored upon binding of Pdx, if, as
expected, the cis conformer is destabilized by the absence of
the hydrogen bond between the carbonyl oxygen of Ile 88 and
the Tyr 29 hydroxyl group. The change in KD for Pdx
r (by a factor
of 10 in Y29F relative to WT) corresponds to destabilization of
the Pdx-bound form of Y29F by 6 kJ/mol, which is appropriate
for the loss of a weak tomedium hydrogen bond. Conversely, the
lack of large spectral perturbations in the Y29Fmutant relative to
WT suggests that the cis conformer is not a significant contribu-
tor to the solution conformations present in the Pdx-free form of
CYP101.
One might ask why, if it is the dominant form in solution in the
absence of Pdx, the trans conformer has not been detected crys-
Figure 7. Distribution of Residues in CYP-S-CO Affected by Pdxr
Titration, Color Coded toMatch Residue Labels in Figures S1 and S2
Slow-exchange residues (Ddmax > 200 Hz) are green, titrating residues are
crimson, and nonperturbed residues are dark blue. Residues in gray are either
unassigned or titration behavior is undetermined due to spectral overlap.
Structural features discussed in the text are labeled.Structurtallographically. Although we cannot answer this question un-
equivocally, it is likely that crystal packing favors the cis form. Fur-
thermore, the barrier to isomerization is not high (vide infra), and
packing forces in the crystal may be sufficient to drive the isom-
erization in situ. It has been shown that crystalline CYP-S-O2 is
capable of turning over substrate in the absence of effector
by using radiolytically generated electrons, confirming that the
crystallographic conformer is catalytically competent (Schlicht-
ing et al., 2000).
Do Local Structural Features in CYP101 Catalyze
Ile 88-Pro 89 Isomerization?
The rate constant for the conformational exchange observed
upon Pdxr binding to WT CYP-S-CO (between 150 s1 and
200 s1 at 298 K and half-saturation [Wei et al., 2005], also see
Figure 1) indicates an activation free energy of60 kJ/mol, which
lies between the barriers for an uncatalyzed X-Pro isomerization
(80 kJ/mol) and those catalyzed by PPIases (50 kJ/mol for
CyA) (Stein, 1993). We might therefore expect the structure of
CYP101 near the Ile 88-Pro 89 dipeptide to have features in
common with the active sites of known PPIases. PPIases are
thought to catalyze X-Pro cis-trans isomerization by providing
a hydrophobic environment for the amide carbonyl (thereby de-
stabilizing the charge-separated O-C = N+ resonance structure
that imparts double-bond character to the C-N bond) and by
providing a localized hydrogen bond donor to stabilize the lone
pair on the amide nitrogen due to developing sp3 character in
the transition state (Stein, 1993). The structure of CYP101 in
the vicinity of the Ile 88-Pro 89 amide bond meets both of these
requirements. The closest side chains to the Ile 88-Pro 89 amide
(Met 28, Tyr 29, Phe 87, Ile 88, Pro 89, and Ile 395) are hydropho-
bic, and there are no water molecules within hydrogen-bonding
distance of the amide in the 3CPP crystal structure. The side
chain hydroxyl of Tyr 29, the only hydrogen bond donor to the
Ile 88-Pro 89 peptide, is positioned such that it stabilizes the
cis conformation of the 88-89 amide, but not the trans conforma-
tion. This hydroxyl group is also in a position to stabilize a devel-
oping electron lone pair on the Pro 89 amide nitrogen by hydro-
gen bonding in the transition state of the isomerization. A
hydrogen bond from a tyrosine hydroxyl group has been pro-
posed to stabilize the sp3 nitrogen electron lone pair in the
transition state of X-Pro isomerization catalyzed by the PPIase
FKBP (Stein, 1993).
One other comparison with PPIases is worth making. Ground-
state binding of the trans substrate conformer by CyA is thought
to involve considerable distortion of the target peptide bond
away from planarity by a combination of steric interactions and
the destabilization of the charge-separated O-C = N+ reso-
nance structure discussed above (Hur and Bruice, 2002; Zhao
and Ke, 1996). If the same holds true for CYP101, one might
expect that the trans conformation of the Ile 88-Pro 89 bond is
likewise distorted in the ground state. (In the cis conformer, the
Tyr 29 OH hydrogen bond is expected to stabilize the charge-
separated resonance form and maintain bond planarity).
Generality of Mechanism
Based on our conclusions regarding Pdx-enforced conforma-
tional selection in CYP101, wemight expect to find similar mech-
anisms active in other P450 enzymes. BLAST multiple sequencee 16, 916–923, June 2008 ª2008 Elsevier Ltd All rights reserved 921
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A Proline Switch in Cytochrome P450camalignment (Altschul et al., 1997) reveals that proline is conserved
at the beginning of the B0 helix in amajority of known and putative
bacterial P450 genes with homology to CYP101 and, if present,
is usually preceded by a hydrophobic residue (Ile, Val, Phe, or
Leu). The samemotif is found in other P450s for which structures
have been determined, and the motif may correlate with en-
zymes that have specific substrates and give products with a sin-
gle regio- or stereochemistry. For example, in CYP2C5 (proges-
terone 21-hydroxylase), Val-Pro precedes the B0 helix, but not in
CYP2B4, which oxidizes a wide range of substrates, despite
72% sequence similarity between the two enzymes. There could
also be a substrate size limitation for this mechanism: in
P450eryF, which is involved in the biosynthesis of a 14-atom
ring macrolide, the B0 helix is preceded by Phe-Pro (Cupp-Vick-
ery and Poulos, 1997), but there is no Pro initiator for the B10 or
B20 helices in P450epoK, which acts on a 16-member macro-
cycle (Nagano et al., 2003).
In summary, our observations support the existence of a hith-
erto unsuspected and functionally relevant X-Pro isomerization
in a well-characterized enzyme. X-Pro isomerizations have
been implicated in a variety of biological switches; thus, it is likely
that such isomerizations can control conformational changes
necessary for efficient activity in enzymes as well.
EXPERIMENTAL PROCEDURES
Site-Directed Mutagenesis
All mutants were generated by using the CYP101 gene encoding the C334A
mutant of CYP101 as template. The C334A mutant has been shown to be
spectroscopically and enzymatically identical to wild-type (WT) CYP101
enzyme, but it does not form dimers in solution and thus is more suitable for
solution NMR studies than WT enzyme (Nickerson and Wong, 1997). For con-
venience, the abbreviationWT in this paper refers to the C334Amutant. A four-
primer mutagenesis protocol was used to introduce mutations. Experimental
methods used for four-primer mutagenesis were described previously
(Pochapsky et al., 2001). The presence of the appropriate mutation was con-
firmed in each case by sequencing the entire CYP101 gene after isolation and
purification of the mutant plasmid.
Mutant proteins were overexpressed, isolated, and purified from Escheri-
chia coli strain NCM533 harboring modified pDNC334A plasmids that
encoded the appropriate mutant of CYP101 under control of the lac promoter
(Nickerson and Wong, 1997). Mutant proteins were expressed and purified by
following standard methods (Rui et al., 2006). The purity of WT CYP101 was
determined spectroscopically. Fractions with an absorption ratio of A391:A280
greater than 1.4 were used for the experiments described below. For mutant
proteins, purity was confirmed by gel electrophoresis.
Activity Assays
Percent uncoupling was determined by gas chromatography from the ratio of
hydroxycamphor to camphor peak areas for fixed amounts of camphor pres-
ent and NADH consumed in a standard reconstituted camphor hydroxylase
assay. Initial reaction rates were determined spectroscopically from the rate
of change in NADH absorption under standard assay conditions. Details of
the assay have been published previously (Rui et al., 2006). Each experiment
was performed at least twice. Single-turnover assays in the absence of effec-
tor were performed as described elsewhere (Tosha et al., 2004).
NMR Spectroscopy
The expression and purification of isotopically labeled CYP101 for NMR sam-
ples has been described previously (Rui et al., 2006). Samples of WT CYP101
were prepared with the following combinations of isotopic labels: uniform
(u)-15N; u-2H,u-15N; u-2H,u-15N, (1H,13C)-Pro, and u-2H,u-15N, (1H,13C)-Pro,
Ile. Mutant proteins were expressed and purified in either the u-15N- or
u-2H,u-15N-labeled form. CYP-S-CO samples for all NMR experiments were922 Structure 16, 916–923, June 2008 ª2008 Elsevier Ltd All rights r0.2–0.4 mM in either 100% D2O or 90% H2O/10% D2O (pH 7.4), 50 mM deu-
terated Tris-Cl, 100 mM KCl, and 2 mM (d)-camphor. Samples of Pdx and
CYP101 were reduced and prepared for spectroscopy by using previously
described methods (Pochapsky et al., 2003). Pdx samples used for titration
were concentrated to 6 mM prior to titration. NMR experiments were per-
formed on a Bruker Avance 800 MHz spectrometer operating at 800.13,
201.2, and 81.08 MHz for 1H, 13C, and 15N, respectively. All NMR experiments
were performed at 25C. Experiments used for sequential resonance assign-
ments and structural analyses have been described previously (Pochapsky
et al., 2003; Wei et al., 2005; OuYang et al., 2006; Rui et al., 2006). Dissociation
constants for Pdxr-CYP-S-CO complexes were calculated from chemical shift
perturbations induced by Pdxr titration as described previously (Pochapsky
et al., 2003).
SUPPLEMENTAL DATA
Supplemental Data include overlays of 1H, 15N TROSY-HSQC spectra show-
ing details of spectral perturbations induced in WT CYP-S-CO upon titration
with Pdxr and introduction of the P89I mutation and are available at http://
www.structure.org/cgi/content/full/16/6/916/DC1/.
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